Guselkumab

Last Updated: 11/08/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1142 publications

Safety profile of IL-23 inhibitors from the perspective of physicians and pharmacists: A retrospective real-world pharmacovigilance observational study based on the FAERS database.

Safety profile of IL-23 inhibitors from the perspective of physicians and pharmacists: A retrospective real-world pharmacovigilance observational study based on the FAERS database.

Journal: Science progress

Published: October 19, 2026

Biologic treatments for palmoplantar psoriasis and palmoplantar pustulosis: a systematic review and network meta-analysis.

Biologic treatments for palmoplantar psoriasis and palmoplantar pustulosis: a systematic review and network meta-analysis.

Journal: European journal of dermatology : EJD

Published: October 12, 2026

Effectiveness of interleukin (IL)-23 and IL-12/23 inhibitors and factors associated with response in psoriatic arthritis with axial involvement: the APxis-IL12-23 study.

Effectiveness of interleukin (IL)-23 and IL-12/23 inhibitors and factors associated with response in psoriatic arthritis with axial involvement: the APxis-IL12-23 study.

Journal: Scandinavian journal of rheumatology

Published: October 09, 2026

Real-World Strategies for Biologic Dose Escalation and Reduction in Psoriasis and Psoriatic Arthritis: A Systematic Review.

Real-World Strategies for Biologic Dose Escalation and Reduction in Psoriasis and Psoriatic Arthritis: A Systematic Review.

Journal: Journal of cutaneous medicine and surgery

Published: September 29, 2026

Clinical and scintigraphic improvement of mandibular involvement associated with chronic nonbacterial osteitis following an interleukin-23 inhibitor: a case-based literature review.

Clinical and scintigraphic improvement of mandibular involvement associated with chronic nonbacterial osteitis following an interleukin-23 inhibitor: a case-based literature review.

Journal: Immunological medicine

Published: September 25, 2026

Medical Therapies Beyond Infliximab for Perianal Fistulizing Crohn's Disease: Current Evidence and Future Perspectives.

Medical Therapies Beyond Infliximab for Perianal Fistulizing Crohn's Disease: Current Evidence and Future Perspectives.

Journal: Journal of clinical medicine

Published: August 17, 2026

Clinical outcomes following switch from risankizumab to guselkumab in Crohn's disease.

Clinical outcomes following switch from risankizumab to guselkumab in Crohn's disease.

Journal: Journal of Crohn's & colitis

Published: August 13, 2026

Refractory verrucous psoriasis achieving clearance with guselkumab and subsequent response to excimer therapy.

Refractory verrucous psoriasis achieving clearance with guselkumab and subsequent response to excimer therapy.

Journal: JAAD case reports

Published: August 09, 2026

Benefit-risk profiling of advanced therapies in moderate-to-severe ulcerative colitis: a clustered network meta-analysis.

Benefit-risk profiling of advanced therapies in moderate-to-severe ulcerative colitis: a clustered network meta-analysis.

Journal: Frontiers in pharmacology

Published: August 08, 2026

Clinical case series: Emergence of psoriatic arthritis during biologic IL-23 pathway inhibition therapy for psoriasis.

Clinical case series: Emergence of psoriatic arthritis during biologic IL-23 pathway inhibition therapy for psoriasis.

Journal: Frontiers in medicine

Published: August 08, 2026

Joint American Academy of Dermatology-Hidradenitis Suppurativa Foundation guidelines of care for the management of hidradenitis suppurativa.

Joint American Academy of Dermatology-Hidradenitis Suppurativa Foundation guidelines of care for the management of hidradenitis suppurativa.

Journal: Journal of the American Academy of Dermatology

Published: August 06, 2026

Differential efficacy of interleukin-23 pathway inhibitors in ulcerative colitis according to disease extent: a systematic review and meta-analysis of randomized trials.

Differential efficacy of interleukin-23 pathway inhibitors in ulcerative colitis according to disease extent: a systematic review and meta-analysis of randomized trials.

Journal: European journal of gastroenterology & hepatology

Published: July 29, 2026

Showing 1-12 of 1,142

Last Updated: 11/08/2026